Related Experiment Videos

[Paroxysmal nocturnal hemoglobinuria--pathophysiological implication of altered glycosylation]

¹Second Department of Internai Medicine, Kumamoto University School of Medicine.

Seikagaku. the Journal of Japanese Biochemical Society

|February 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.

Leukemia·2011

Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis.

Leukemia·2009

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML.

Leukemia·2008

Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.

International journal of hematology·2000

A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription.

International journal of hematology·2000

Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.

British journal of haematology·1998

See all related articles